Navigation Links
Uroplasty Highlights Clinical Results From a Study of the Urgent(R) PC Neuromodulation System
Date:5/21/2008

The Urgent PC neuromodulation system is a proprietary, minimally invasive nerve stimulation device designed for office-based treatment of urge incontinence, urinary urgency and urinary frequency, symptoms often associated with overactive bladder. Application of neuromodulation therapy targets specific nerve tissue and disrupts the signals that lead to these symptoms. Uroplasty sells the Urgent PC system in the United States, Canada, and countries recognizing the CE mark. Outside of the United States, Urgent PC is also indicated for the treatment of fecal incontinence.

About Uroplasty, Inc.

Uroplasty, Inc., headquartered in Minnetonka, Minnesota, with wholly owned subsidiaries in The Netherlands and the United Kingdom, is a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions. Our primary focus is the commercialization of our Urgent PC system, which we believe is the only FDA-approved non-surgical neurostimulation therapy for the treatment of urinary urgency, urinary frequency and urge incontinence, symptoms often associated with a diagnosis of overactive bladder (OAB). We also offer Macroplastique(R) Implants, an injectable, minimally invasive urethral bulking agent for the treatment of adult female stress urinary incontinence. Please visit Uroplasty, Inc. at http://www.uroplasty.com.

For Further Information:

Uroplasty, Inc.

David Kaysen, President and CEO, or

Medi Jiwani, Vice President, CFO, and Treasurer,

952.426.6140

EVC Group

Doug Sherk/Matt Selinger (Investors)

415.896.6820

Chris Gale (Media)

646.201.5431


'/>"/>
SOURCE Uroplasty, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
2. Five-Year Data From Taxus II Clinical Trial Highlights Safety and Efficacy of Taxus(R) Stent Compared to Bare-Metal Stent
3. President Clinton Highlights MWW Group at the 2007 Clinton Global Initiative for its Stop Neglected Tropical Disease Campaign
4. Genaera Corporation Provides Highlights of Positive Phase 1 Trodusquemine (MSI-1436) Data from the North American Association for the Study of Obesity Annual Meeting
5. Schering-Plough Highlights PEGINTRON(TM) Clinical Data Presentations at the American Association for the Study of Liver Diseases (AASLD) 2007 Annual Meeting
6. Synvista Therapeutics Highlights New Data Demonstrating the Clinical Benefit of Vitamin E Therapy in Patients Identified on the Basis of Haptoglobin Phenotype Testing
7. Research Highlights Potential Benefits of Telemedicine in Treating Eye Disease
8. Sarasotas Roskamp Institute Highlights Positive Japanese Data that Validates its Ongoing Alzheimers Disease Research
9. Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights
10. Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting
11. Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:FDA Makes Interim Recommendations to Address Concern of Excess Radiation Exposure during CT Perfusion Imaging 2FDA Makes Interim Recommendations to Address Concern of Excess Radiation Exposure during CT Perfusion Imaging 3CompuCyte Announces the Release of Four-Laser Imaging Cytometers 2Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 2Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 3Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 4Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 5Reportlinker Adds Worldwide Optical Transmission TEM and Scanning SEM Electron Microscope Market Shares Strategies and Forecasts 2009 to 2015 14647 1Reportlinker Adds Worldwide Optical Transmission TEM and Scanning SEM Electron Microscope Market Shares Strategies and Forecasts 2009 to 2015 14647 2Reportlinker Adds Worldwide Optical Transmission TEM and Scanning SEM Electron Microscope Market Shares Strategies and Forecasts 2009 to 2015 14647 3Reportlinker Adds Worldwide Optical Transmission TEM and Scanning SEM Electron Microscope Market Shares Strategies and Forecasts 2009 to 2015 14647 4Reportlinker Adds Worldwide Optical Transmission TEM and Scanning SEM Electron Microscope Market Shares Strategies and Forecasts 2009 to 2015 14647 5Reportlinker Adds Worldwide Optical Transmission TEM and Scanning SEM Electron Microscope Market Shares Strategies and Forecasts 2009 to 2015 14647 6Reportlinker Adds Worldwide Optical Transmission TEM and Scanning SEM Electron Microscope Market Shares Strategies and Forecasts 2009 to 2015 14647 7Reportlinker Adds Worldwide Optical Transmission TEM and Scanning SEM Electron Microscope Market Shares Strategies and Forecasts 2009 to 2015 14647 8Reportlinker Adds Worldwide Optical Transmission TEM and Scanning SEM Electron Microscope Market Shares Strategies and Forecasts 2009 to 2015 14647 9Reportlinker Adds Worldwide Optical Transmission TEM and Scanning SEM Electron Microscope Market Shares Strategies and Forecasts 2009 to 2015 14647 10Reportlinker Adds Worldwide Optical Transmission TEM and Scanning SEM Electron Microscope Market Shares Strategies and Forecasts 2009 to 2015 14647 11Nonin Medical Recognized for Influential Contributions in Medical Technology 5845 1Nonin Medical Recognized for Influential Contributions in Medical Technology 5845 2Neuro Kinetics 26amp 3B Military Researchers in Push To Improve Diagnosis 26amp 3B Treatment of Combat Brain Injuries 5842 1Neuro Kinetics 26amp 3B Military Researchers in Push To Improve Diagnosis 26amp 3B Treatment of Combat Brain Injuries 5842 2